Maxcyte (DI) (MXCT)

Index:

FTSE AIM 100

292.00p
   
  • Change Today:
    -3.00p
  • 52 Week High: 420.00
  • 52 Week Low: 210.00
  • Currency: UK Pounds
  • Shares Issued: 104.40m
  • Volume: 0
  • Market Cap: £304.84m

Latest ShareCast News

MaxCyte reports strong fourth quarter as full-year revenues fall

By Josh White

Date: Wednesday 13 Mar 2024

(Sharecast News) - Cell engineering technology specialist MaxCyte reported total fourth quarter revenue of $15.7m on Wednesday, up 26% on the same period in 2022.

MaxCyte flags lower 2023 revenue, flat 2024 growth

By Josh White

Date: Tuesday 05 Mar 2024

(Sharecast News) - Cell engineering technology specialist MaxCyte said in an update on Tuesday that it expected total 2023 revenue of between $41.1m and $41.3m, down from $44.3m in 2022.

MaxCyte flags uptick in total fourth-quarter revenue

By Josh White

Date: Tuesday 09 Jan 2024

(Sharecast News) - Cell engineering company MaxCyte said on Tuesday that total fourth-quarter revenue was expected to be between $15.5m and $15.7m.

Maher Masoud starts as MaxCyte president, CEO 02-Jan-2024 ShareCast
MaxCyte announces new CEO, updates revenue guida... 12-Dec-2023 ShareCast
MaxCyte joins Alliance for mRNA Medicines 16-Nov-2023 ShareCast
MaxCyte lowers full-year guidance after weaker t... 05-Oct-2023 ShareCast
MaxCyte signs licence deal with Vittoria Biother... 10-Jul-2023 ShareCast
MaxCyte inks platform licensing deal with Lyell 06-Jul-2023 ShareCast
MaxCyte revises guidance after weaker first quar... 11-May-2023 ShareCast
MaxCyte installs Douglas Swirsky as its new fina... 28-Mar-2023 ShareCast
MaxCyte expecting strong 2023 after decent results 16-Mar-2023 ShareCast
MaxCyte flags 2022 revenue growth, sets new guid... 07-Mar-2023 ShareCast
MaxCyte signs strategic platform licence with Ca... 04-Jan-2023 ShareCast
MaxCyte inks deal with South Korea's Curamys 05-Dec-2022 ShareCast
MaxCyte revenues improve in third quarter 10-Nov-2022 ShareCast
MaxCyte hikes guidance after solid first half 11-Aug-2022 ShareCast
MaxCyte reports good first quarter revenue growth 10-May-2022 ShareCast
MaxCyte CFO resigns, first quarter revenues rise 13-Apr-2022 ShareCast
MaxCyte reports record Q4 and full-year revenue 23-Mar-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 292.00p
Change Today -3.00p
% Change -1.02 %
52 Week High 420.00
52 Week Low 210.00
Volume 0
Shares Issued 104.40m
Market Cap £304.84m

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Top of Page